Search results
Results from the WOW.Com Content Network
Some drugs are not allowed in competition and may need to be withheld a few days before. Adding potassium and salt to the diet may be beneficial to horses that suffer from recurrent bouts of ER both chronic and sporadic. Horses in hard training may need a vitamin E supplement, as their requirements are higher than horses in more moderate work.
Main page; Contents; Current events; Random article; About Wikipedia; Contact us; Pages for logged out editors learn more
Flunixin is a nonsteroidal anti-inflammatory drug (NSAID), analgesic, and antipyretic used in horses, cattle and pigs. It is often formulated as the meglumine salt. In the United States, it is regulated by the U.S. Food and Drug Administration (FDA), and may only be lawfully distributed by order of a licensed veterinarian. There are many trade ...
This article lists veterinary pharmaceutical drugs alphabetically by name. Many veterinary drugs have more than one name and, therefore, the same drug may be listed more than once. Abbreviations are used in the list as follows: INN = International Nonproprietary Name; BAN = British Approved Name; USAN = United States Adopted Name
E. Eastern equine encephalitis; Endometrosis; Epizootic lymphangitis; Equid alphaherpesvirus 4; Equid gammaherpesvirus 2; Equid gammaherpesvirus 5; Equine atypical myopathy
Strangles (also called equine distemper) is a contagious upper respiratory tract infection of horses and other equines caused by a Gram-positive bacterium, Streptococcus equi. [1] As a result, the lymph nodes swell, compressing the pharynx , larynx , and trachea , and can cause airway obstruction leading to death, hence the name strangles. [ 2 ]
Firocoxib, sold under the brand names Equioxx and Previcox among others, is a nonsteroidal anti-inflammatory drug of the COX-2 inhibitor (coxib) class, approved for use in horses (Equioxx) and for use in dogs (Previcox). [2] [4] [9] Firocoxib was the first COX-2 inhibitor approved by the U.S. Food and Drug Administration for horses. [10]
Ponazuril (), sold by Merial, Inc., [1] now part of Boehringer Ingelheim, [2] under the trade name Marquis (15% w/w ponazuril), is a drug currently approved for the treatment of equine protozoal myeloencephalitis (EPM) in horses, caused by coccidia Sarcocystis neurona.